Trump's AI Executive Order Has a $100 Million Lobby Behind It

Sam Altman is backing Merge Labs, a new brain-computer interface venture exploring a gene therapy approach to connect human brains with AI. The company is considering genetically modifying brain cells to respond to ultrasound, enabling a less invasive implant system. Merge is currently raising $250 million at an $850 million valuation, with major backing expected from OpenAI’s venture arm. This move positions Altman in direct competition with Elon Musk’s Neuralink, which uses electrode-based implants. Merge’s approach combines sonogenetics and embedded ultrasound hardware, aiming for high-bandwidth communication between thought and AI systems. Altman is co-founding the project but won’t take a day-to-day role or personally invest.

17 Aug 6min

Built for any adventure, Cybertruck has a durable exterior, spacious interior and technological capabilities so you can pack up your gear and hit the road.Originally Published: November 30, 2023 at 6:00 PM

16 Aug 13min

SpaceX Starship Flight 10 Launch Update #news #spacex #elonmusk

15 Aug 13min

Chris Van Hollen says Elon Musk's DOGE Cuts Delayed Social Security Payments And Harmed Customer Service

14 Aug 9min

Elon Musk Suing Apple because Grok isn't #1

13 Aug 23min

Musk Ordered Starlink Blackout During Key Ukraine Offensive

12 Aug 8min

rivian fighting OHIO for dealership license

11 Aug 8min

$6 Billion from $150K investment in Tesla

8 Aug 13min